Plain-English translation of NCT07349121 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying a newer approach to treating atrial fibrillation (irregular heartbeat) called pulsed field ablation using the FARAPULSE system, combined with implanting a WATCHMAN device to reduce stroke risk—all done in one procedure instead of two separate surgeries. Researchers want to gather real-world data to see how well this combined approach works for patients who need both treatments.
Currently, patients with atrial fibrillation often need two separate procedures: one to fix the irregular heartbeat and another to close part of the heart to prevent stroke. This trial is exploring whether doing both treatments at the same time could be safer, more effective, and easier for patients.
You likely qualify if…
You likely don't qualify if…
You would come to an approved hospital or center for one interventional procedure where doctors perform both the heart rhythm ablation and implant the stroke prevention device in the same surgery. After the procedure, you would attend follow-up visits and complete testing as part of the study to monitor how well the treatment works and ensure your safety.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Belgium
Croatia
France
Italy
Spain